Hoffmann-La Roche: Glioblastoma trials
The registry lists 13 Glioblastoma studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 3Phase 2 7Phase 3 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent GlioblastomaCompletedNCT01474239Phase 2Results posted
- A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma MultiformeCompletedNCT01115491Phase 2Results posted
- A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With GlioblastomaCompletedNCT00967330Phase 2Results posted
- A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed GlioblastomaCompletedNCT00943826Phase 3Results posted
- A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With GlioblastomaCompletedNCT05187624Phase 1
- A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With GlioblastomaCompletedNCT01860638Phase 2
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent GlioblastomaCompletedNCT01632228Phase 2
- An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second RelapseCompletedNCT01618747
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade GliomaCompletedNCT01547546Phase 1
- A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaCompletedNCT01308684Phase 1
- A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)CompletedNCT00345163Phase 2
- A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)CompletedNCT00337883Phase 2